The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -33.43% this year. Over the last six months, there has been a stronger performance of -17.49%. The price of CYTK leaped by -2.24% during the last 30 days period. For the last 5-days stocks have improved 2.81%.
Cytokinetics Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $110.25 on 01/08/24, and the lowest price during that time was $25.98, recorded on 10/04/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of CYTK Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Cytokinetics Inc’s current trading price is -49.59% away from its 52-week high, while its distance from the 52-week low is 113.93%. The stock’s price range over this timeframe has been between $25.98 and $110.25. The shares of the Healthcare sector company recorded a trading volume of approximately 1.21 million for the day, which was comparatively lower than the average daily volume of 1.41 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Cytokinetics Inc (CYTK) has experienced a quarterly rise of 7.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.54B and boasts a workforce of 423 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 56.07, with a change in price of -10.25. Similarly, Cytokinetics Inc recorded 1,737,404 in trading volume during the last 100 days, posting a change of -15.69%.
CYTK’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CYTK stands at 7.28. Similarly, the long-term debt-to-equity ratio is also 7.00.
CYTK Stock Stochastic Average
The raw stochastic average for Cytokinetics Inc over the last 50 days is presently at 39.07%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 38.36%. Further, the company’s Stochastic %K and %D values for the last 20 days were 49.38% and 55.61%, respectively.
